Therapeutic research
Our tools support the discovery of new medicines. We decline uses that could reasonably be expected to cause harm.
Responsible AI × Biodesign
We use AI to study biological targets and design potential medicines. Scientists assess the results and decide what to test.
Our principles
Scientific oversight
Scientists check model outputs against the evidence and take responsibility for research decisions.
Experimental evidence
A prediction is a starting point for further research. Laboratory testing is needed to establish whether a candidate works as expected.
Misuse and access
We consider who can access our tools, what they can produce, and how those outputs could be misused.
Research scope
Our platform brings together target analysis, molecular modeling, and small-molecule design. When we commission laboratory work, qualified research partners carry it out under their own biosafety requirements.
Governance
Draft — pending formal adoption
We are drafting a policy for reviewing tools before release. It will cover intended use, access, potential misuse, and the measures needed to reduce those risks. Formal adoption and independent review are still pending.
- Legal entity
- BinB S.r.l. / NeoraLab
- Scientific lead
- Marco Ferrarini, Chief Scientific Officer
Contact
For questions about this work or to report a concern, email [email protected].